TAM JAI INTL(02217) mid-term profit after tax was 36 million Hong Kong dollars, a decrease of 56.1% year-on-year.
Tanzi International (02217) announced that for the six months ended September 30, 2024, it achieved revenue of 1.404 billion...
TAM JAI INTL (02217) announced that, for the six months ended September 30, 2024, the company achieved revenue of 1.404 billion Hong Kong dollars, an increase of 1.23% year-on-year; the net profit after tax was 36 million Hong Kong dollars, a decrease of 56.1% year-on-year.
Related Articles
Sino-High (301076.SZ): The annual production of 8,000 tons of acetophenone and its supporting project three workshops have entered the trial production stage.
Shanghai Shyndec Pharmaceutical's subsidiary obtains the drug registration certificate for Tafurinol eye drops.
China Post Securities: The cost-effectiveness of consumer building materials is highlighted, focusing on low-end varieties of domestic demand.
Sino-High (301076.SZ): The annual production of 8,000 tons of acetophenone and its supporting project three workshops have entered the trial production stage.
Shanghai Shyndec Pharmaceutical's subsidiary obtains the drug registration certificate for Tafurinol eye drops.
China Post Securities: The cost-effectiveness of consumer building materials is highlighted, focusing on low-end varieties of domestic demand.
RECOMMEND
